Maternal adaptation to high-altitude pregnancy: An experiment of nature - A review

Placenta

Volumn 25, Issue SUPPL. A, 2004, Pages

  Moore, Lorna G ^a,b   Shriver, M ^c   Bemis, L ^b   Hickler, B ^a   Wilson, M ^a   Brutsaert, T ^d   Parra, E ^c,e   Vargas, E ^f  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c PENNSYLVANIA STATE UNIVERSITY   (United States)

^d STATE UNIVERSITY OF NEW YORK   (United States)

^e UNIVERSITY OF TORONTO   (Canada)

^f Instituto Boliviano de Biologia de Altura   (Bolivia)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1; HYPOXIA INDUCIBLE FACTOR 1;

ALTITUDE ACCLIMATIZATION; ALTITUDE DISEASE; BIRTH WEIGHT; CONCENTRATION (PARAMETERS); DISEASE PREDISPOSITION; EUROPE; FEMALE; GENE TARGETING; GENETIC SUSCEPTIBILITY; HUMAN; HYPOTHESIS; INTRAUTERINE GROWTH RETARDATION; NATURAL SELECTION; PLACENTA CIRCULATION; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; REGULATOR GENE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; WEIGHT REDUCTION;

EID: 1942454876     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2004.01.008     Document Type: Article

References (142)

1. Niermeyer S, Zamudio S, Moore LG. The people. In: Hornbein T, Schoene RB, editors. Adaptations to hypoxia. New York (NY): Marcel Dekker and Co; 2001, p. 43-100.
2. Lichty JL, Ting R, Bruns PD, Dyar E. Studies of babies born at high altitude. Am J Dis Child 1957;93:666-9.
3. Moore LG. Small babies and big mountains: John Lichty solves a Colorado mystery in Leadville. In: Reeves JT, Grover FT , editors. Attitudes on altitude. Boulder: Univ Colorado Press; 2001b, p. 137-59.
4. Lubchenco LO. Intrauterine growth as estimated from liveborn birthweight data at 24 to 42 weeks of gestation. Pediatrics 1963;32:793-800.
5. Moore LG, Hershey DW, Jahnigen D, Bowes W Jr. The incidence of pregnancy-induced hypertension is increased among Colorado residents at high altitude. Am J Obstet Gynecol 1982a;144:423-9.
6. Ahmed A, Dunk C, Ahmad S, Khaliq A. Regulation of placental vascular endothelial growth factor (VEGF) and placenta growth factor (PLGF) and soluble Flt-1 by oxygen - a review. Placenta 2000;21:S16-24.
7. Genbacev O, Krtolica A, Kaelin W, Fisher SJ. Human cytotrophoblast expression of the von Hippel-Lindau protein is downregulated during uterine invasion in situ and upregulated by hypoxia in vitro. Dev Biol 2001;233:526-36.
8. Caniggia I, Winter JL. Hypoxia inducible factor-1: oxygen regulation of trophoblast differentiation in normal and pre-eclamptic pregnancies - a review. Placenta 2002;23:S47-57.
9. Rajakumar A, Doty K, Daftary A, Harger G, Conrad KP. Impaired oxygen-dependent reduction of HIF-1alpha and -2alpha proteins in pre-eclamptic placentae. Placenta 2003;24:199-208.
10. Kaufmann P, Black S, Huppertz B. Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol Reprod 2003;69:1-7.
11. Jensen GM, Moore LG. The effect of high altitude and other risk factors on birthweight: independent or interactive effects?. Am J Public Health 1997;87:1003-7.
12. Giussani DA, Seamus P, Anstee S, Barker DJP. Effects of altitude versus economic status on birth weight and body shape at birth. Pediatr Res 2001;49:490-4.
13. Mortola JP, Frappell PB, Aguero L, Armstrong K. Birth weight and altitude: a study in Peruvian communities. J Pediatr 2000;136:324-9. 14 Unger C, Weiser JK, McCullough RE, Keefer S, Moore LG. Altitude, low birth weight, and infant mortality in Colorado. J Am Med Assoc 1988;259:3427-32.
14. Unger C, Weiser JK, McCullough RE, Keefer S, Moore LG. Altitude, low birth weight, and infant mortality in Colorado. J Am Med Assoc 1988;259:3427-32.
15. Krampl E, Lees C, Bland JM, Dorado JE, Gonzalo M, Campbell S. Fetal biometry at 4300 in compared to sea level in Peru. Ultrasound Obstet Gynecol 2000;16:9-18.
16. Palmer SK, Moore LG, Young DA, Cregger B, Berman JC, Zamudio S. Altered blood pressure course during normal pregnancy and increased preeclampsia at high altitude (3100 meters) in Colorado. Am J Obstet Gynecol 1999;180:1161-8.
17. Keyes LE, Armaza JF, Niermeyer S, Vargas E, Young D, Villena M et al. Intrauterine growth restriction, preeclampsia and intrauterine mortality at high altitude in Bolivia. Pediatr Res 2003 in press.
18. Niermeyer S. Cardiopulmonary transition in the high altitude neonate. High Alt Med Biol 2003;4:225-39.
19. McCullough RE, Reeves JT, Liljegren RL. Fetal growth retardation and increased infant mortality at high altitude. Arch Environ Health 1977; 32:36-40.
20. PAHO. Health conditions in the Americas. Scientific publication No. 549. Washington (DC, USA): World Health Organization (Pan American Health Organization), 1994.
21. Wiley AS. Neonatal size and infant mortality at high altitude in the western Himalaya. Am J Phys Anthropol 1994;94:289-305.
22. Bolivia Ro. Encuesta Nacional de Demografia y Salud. Calverton (MD, USA): Macro International/DHS+ Program, 1998.
23. Giussani D. High altitude and rural living are associated with increased infant mortality in Bolivia. J Soc Gynecol Investig 2002;9:292A.
24. PAHO. Epidemiol Bull 1999;20(3):14-9.
25. Haas JD. Human adaptability approach to nutritional assessment: a Bolivian example. Fed Proc 1981;40:2577-82.
26. Moore LG. Human genetic adaptation to high altitude. High Alt Med Biol 2001a;2:257-79.
27. Moore LG, Young DY, McCullough RE, Droma TS, Zamudio S. Tibetan protection from intrauterine growth restriction (IUGR) and reproductive loss at high altitude. Am J Human Biol 2001a;13:635-44.
28. Weinstein RS, Haas JD. Early stress and later reproductive performance under conditions of malutrition and high altitude hypoxia. Med Anthropol 1977;1:25-54.
29. Moore LG, Rounds SS, Jahnigen D, Grover RF, Reeves JT. Infant birth weight is related to maternal arterial oxygenation at high altitude. J Appl Physiol 1982b;52:695-9.
30. Chakraborty R, Barton SA, Ferrell RE, Schull WJ. Ethnicity determination by names among the Aymara of Chile and Bolivia. Hum Biol 1989; 61:159-77.
31. Moore LG, Armaza F, Keyes L, Borth R, Niermeyer S, Villena M et al. Andean compared with European babies are protected from altitude-associated intrauterine growth restriction (IUGR). High Alt Med Biol 2002;4:460 (abstract).
32. Chapman AB, Abraham WT, Osorio FV, Merouani A, Zamudio S, Young DA et al. Temporal relationships between hormonal and hemodynamic changes in early human pregnancy. Kidney Int 1998; 54:2056-63.
33. Cadnapaphornchai MA, Ohara M, Morris KG Jr, Knotek M, Rogachev B, Ladtkow T et al. Chronic NOS inhibition reverses systemic vasodilation and glomerular hyperfiltration in pregnancy. Am J Physiol Renal Physiol 2001;280:F592-8.
34. Furuhashi N, Kimura H, Nagae H, Yajima A. Maternal plasma endothelin levels and fetal status in normal and preeclamptic pregnancies. Gynecol Obstet Invest 1995;39:88-92.
35. Luttun A, Carmeliet P. Soluble VEGF receptor Flt1: the elusive preeclampsia factor discovered?. J Clin Invest 2003;111:600-2.
36. Maynard SE, Min J-Y, Merchan J, Lim K-H, Li J, Mondal S et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003;111:649-58.
37. Palmer SK, Zamudio S, Coffin C, Parker S, Stamm E, Moore LG. Quantitative estimation of human uterine artery blood flow and pelvic blood flow redistribution in pregnancy. Obstet Gynecol 1992;80:1000-6.
38. Moll W, Kunzel W. The blood pressure in arteries entering the placentae of guinea pigs, rats, rabbits, and sheep. Pflugers Arch 1973;338:125-31.
39. Stock M, Metcalfe J. Maternal physiology during gestation. In: Knobil E, Neil J, editors. The physiology of reproduction. New York: Raven Press; 1994, p. 947-83.
40. Weiner CP, Thompson LP, Liu KZ, Herrig JE. Endothelium-derived relaxing factor and indomethacin-sensitive contracting factor alter arterial contractile responses to thromboxane during pregnancy. Am J Obstet Gynecol 1992;166:1171-8.
41. White MM, McCullough RE, Dyckes R, Robertson AD, Moore LG. Chronic hypoxia, pregnancy, and endothelium-mediated relaxation in guinea pig uterine and thoracic arteries. Am J Physiol Heart Circ Physiol 2000;278:H2069-75.
42. Mateev S, Sillau AH, Mouser R, McCullough RE, White MM, Young DA et al. Chronic hypoxia opposes pregnancy-induced increase in uterine artery vasodilator response to flow. Am J Physiol Heart Circ Physiol 2003;284:H820-9.
43. Weiner C, Liu KZ, Thompson L, Herrig J, Chestnut D. Effect of pregnancy on endothelium and smooth muscle: their role in reduced adrenergic sensitivity. Am J Physiol 1991;261:H1275-83.
44. White MM, McCullough RE, Dyckes R, Robertson AD, Moore LG. Effects of pregnancy and chronic hypoxia on contractile responsiveness to α-1-adrenergic stimulation. J Appl Physiol 1998;85:2322-9.
45. Mateev S, Mouser R, Min L, Moore LG. Chronic hypoxia augments uterine artery distensibility and increases myogenic tone during pregnancy. J Soc Gynecol Investig 2002;9:299A.
46. Cipolla M, Osol G. Hypertrophic and hyperplastic effects of pregnancy on the rat uterine arterial wall. Am J Obstet Gynecol 1994;171:805-11.
47. Keyes LE, Majack R, Dempsey EC, Moore LG. Pregnancy stimulation of DNA synthesis and uterine blood flow in the guinea pig. Pediatr Res 1997;41:708-15.
48. Keyes LE, Moore LG, Walchak SJ, Dempsey EC. Pregnancy-stimulated growth of vascular smooth muscle cells: importance of protein kinase C-dependent synergy between estrogen and platelet-derived growth factor. J Cell Physiol 1996;166:22-32.
49. Celia G, Osol G. VEGF modulates uterine veno-arterial communication through a PLC-PKC signaling cascade that is indepedent of nitric oxide. J Soc Gynecol Investig 2002;9:86A.
50. Mulvany MJ, Baumbach GL, Aalkjaer C, Heagerty AM, Korsgaard N, Schiffrin EL et al. Vascular remodeling. Hypertension 1996;28:5054.
51. Ni Y, May V, Braas K, Osol G. Pregnancy augments uteroplacental vascular endothelial growth factor gene expression and vasodilator effects. Am J Physiol Heart Circ Physiol 1997;273:H938-44.
52. Moore LG, Jahnigen D, Rounds SS, Reeves JT, Grover RF. Maternal hyperventilation helps preserve arterial oxygenation during high-altitude pregnancy. J Appl Physiol 1982c;52:690-4.
53. McAuliffe F, Kametas N, Krampl E, Ernsting J, Nicolaides K. Blood gases in pregnancy at sea level and at high altitude. Br J Obstet Gynaecol 2001;108:980-5.
54. Moore LG, Brodeur P, Chumbe O, D'Brot J, Hofmeister S, Monge C. Maternal hypoxic ventilatory response, ventilation, and infant birth weight at 4,300 m. J Appl Physiol 1986;60:1401-6.
55. Moore LG, Zamudio S, Zhuang J, Sun S, Droma T. Oxygen transport in Tibetan women during pregnancy at 3658 m. Am J Phys Anthropol 2001b;114:42-53.
56. Kitanaka T, Gilbert RD, Longo LD. Maternal responses to long-term hypoxemia in sheep. Am J Physiol 1989;256:R1340-7.
57. Harrison GL, Moore LG. Systemic vascular reactivity during high-altitude pregnancy. J Appl Physiol 1990;69:201-6.
58. Zamudio S, Palmer SK, Dahms TE, Berman JC, McCullough RG, McCullough RE et al. Blood volume expansion, preeclampsia, and infant birth weight at high altitude. J Appl Physiol 1993;75:1566-73.
59. Kametas NA, Savvidou MD, Donald AE, McAuliffe F, Nicolaides KH. Flow-mediated dilatation of the brachial artery in pregnancy at high altitude. Br J Obstet Gynaecol 2002;109:930-7.
60. Mazzeo RS, Child A, Butterfield GE, Mawson JT, Zamudio S, Moore LG. Catecholamine response during 12 days of high-altitude exposure (4,300 m) in women. J Appl Physiol 1998;84:1151-7.
61. Morganti A, Giussani M, Sala C, Gazzano G, Marana I, Pierini A et al. Effects of exposure to high attitude on plasma endothelin-1 levels in normal subjects. J Hypertens 1995;13:859-65.
62. Thaete LG, Neerhof MG, Caplan MS. Endothelin receptor A antagonism prevents hypoxia-induced intrauterine growth restriction in the rat. Am J Obstet Gynecol 1997;176:73-6.
63. Thaete LG, Neerhof MG. Contribution of endothelin to the regulation of uterine and placental blood flow during nitric oxide synthase inhibition in the pregnant rat. 7th International Conference on Endothelin, 2001, p. 222.
64. Zamudio S, Palmer SK, Droma T, Stamm E, Coffin C, Moore LG. Effect of altitude on uterine artery blood flow during normal pregnancy. J Appl Physiol 1995a;79:7-14.
65. Zamudio S, Palmer SK, Dahms TE, Berman JC, Young DA, Moore LG. Alterations in uteroplacental blood flow precede hypertension in preeclampsia at high altitude. J Appl Physiol 1995b;79:15-22.
66. Kublickiene KR, Lindblom B, Kruger K, Nisell H. Preeclampsia: evidence for impaired shear stress-mediated nitiric oxide release in uterine circulation. Am J Obstet Gynecol 2000;183:160-6.
67. Rockwell LC, Keyes LE, Moore LG. Chronic hypoxia diminishes pregnancy-associated DNA synthesis in guinea pig uteroplacental arteries. Placenta 2000;21:313-9.
68. White MM, Moore LG, Mouser R, Le Cras TD. Effect of pregnancy and chronic hypoxia on endothelial nitric oxide synthase (NOSIII) protein expression in guinea pig uterine and thoracic arteries. J Soc Gynecol Investig 2001;8:187A.
69. Gilbert RD, Cummings LA, Juchau MR, Longo LD. Placental diffusing capacity and fetal development in exercising or hypoxic guinea pigs. J Appl Physiol 1979;46:828-34.
70. Jacobs R, Roninson JS, Owens JA, Falconer J, Webster ME. The effect of prolonged hypobaric hypoxia on growth of fetal sheep. J Dev Physiol 1988;10:97-112.
71. Zhang L, Xiao D, Bouslough DB. Long-term high-altitude hypoxia increases plasma nitrate levels in pregnant ewes and their fetuses. Am J Obstet Gynecol 1998;179:1594-8.
72. Xiao D, Liu Y, Pearce WJ, Zhang L. Endothelial nitric oxide release in isolated perfused ovine uterine arteries: effect of pregnancy. Eur J Pharmacol 1999;367:223-30.
73. Xiao D, Pearce WJ, Zhang L. Pregnancy enhances endothelium-dependent relaxation of ovine uterine artery: role of NO and intracellular Ca(2+). Am J Physiol Heart Circ Physiol 2001;281:H183-90.
74. Hu XQ, Longo LD, Gilbert RD, Zhang L. Effects of long-term high-altitude hypoxemia on alpha 1-adrenergic receptors in the ovine uterine artery. Am J Physiol 1996;270:H1001-7.
75. Hu XQ, Zhang L. Chronic hypoxia suppresses pharmacomechanical coupling of the uterine artery in near-term pregnant sheep. J Physiol (Lond) 1997;499:551-9.
76. White MM, Zhang L. Effects of chronic hypoxia on maternal vascular changes in guinea pig and ovine pregnancy. High Alt Med Biol 2003; 4:157-69.
77. Chen D, Zhou X, Zhu Y, Zhu T, Wang J. Comparison study on uterine and umbilical artery blood flow during pregnancy at high altitude and at low altitude. Zhonghua Fu Chan Ke Za Zhi 2002;37:69-71.
78. Krampl E, Espinoza-Dorado J, Lees CC, Moscoso G, Bland JM. Maternal uterine artery Doppler studies at high altitude and sea level. Ultrasound Obstet Gynecol 2001;18:578-82.
79. Rockwell LC, Moore LG. Maternal physiological adaptation to pregnancy. Am J Human Biol 2003 in press.
80. Ward K, Hata A, Jeunemaitre X, Helin C, Nelson L, Namikawa C et al. A molecular variant of angiotensinogen associated with preeclampsia [see comments]. Nat Genet 1993;4:59-61.
81. Angrimsson R, Hayward C, Nadaud S, Baldursdottir A, Walker JJ, Liston WA et al. Evidence for a familial pregnancy-induced hypertension locus in the eNOS-gene region. Am J Hum Genet 1997;61:354-62.
82. Lie RT, Rasmussen S, Brunborg H, Gjessing HK, Lie-Nielsen E, Irgens LM. Fetal and maternal contributions to risk of pre-eclampsia: population based study. BMJ 1998;316:1343-7.
83. Hubel CA, Roberts JM, Ferrell RE. Association of pre-eclampsia with common coding sequence variations in the lipoprotein lipase gene. Clin Genet 1999;56:289-96.
84. Savvidou MD, Valance PJT, Nicolaides KH, Hingorani AD. Endothelial nitric oxide synthase gene polymorphism and maternal vascular adaptation to pregnancy. Hypertension 2001;38:1289-93.
85. Lindsay RS, Kobes S, Knowler WC, Hanson RL. Genome-wide linkage analysis assessing parent-of-origin effects in the inheritance of birth weight. Hum Genet 2002;110:503-9.
86. Safran M, Kaelin WG Jr. HIF hydroxylation and the mammalian oxygen-sensing pathway. J Clin Invest 2003;111:779-83.
87. Huang J, Zhao Q, Mooney SM, Lee FS. Sequence determinants in hypoxia-inducible factor-1alpha for hydroxylation by the prolyl hydroxylases PHD1, PHD2, and PHD3. J Biol Chem 2002;277:39792-800.
88. 2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol 1999;15:551-78.
89. Ratcliffe PJ, O'Rourke JF, Maxwell PH, Pugh CW. Oxygen sensing, hypoxia-inducible factor-1 and the regulation of mammalian gene expression. J Exp Biol 1998;201:1153-62.
90. Renner W, Kotschan S, Hoffmann C, Obermayer-Pietsch B, Pilger E. A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J Vasc Res 2000;37:443-8.
91. Black WC, Baer CF, Antolin MF, DuTeau NM. Population genomics: genome-wide sampling of insect populations. Annu Rev Entomol 2001; 46:441-69.
92. Schlotterer C. Hitchhiking mapping - functional genomics from the population genetics perspective. Trends Genet 2003;19:32-8.
93. Lewontin RC. Ken-Ichi Kojima September 17, 1930-November 14, 1971. Genetics 1972;71(Suppl 2):s89-90.
94. Akey JM, Zhang G, Zhang K, Jin L, Shriver MD. Interrogating a high-density SNP map for signatures of natural selection. Genome Res 2002;12:1805-14.
95. Cavali-Sforza LL. Population structure and human evolution. Proc R Soc Lond B Biol Sci 1966;164:362-79.
96. Hamblin MT, Thompson EE, Di Rienzo A. Complex signatures of natural selection at the Duffy blood group locus. Am J Hum Genet 2002;70:369-83.
97. Shriver MD, Kennedy GC, Parra EJ, Lawson HA, Huang J, Makova K et al. The genomic distribution of human population substructure. 2003; in review.
98. Bamshad M, Wooding SP. Signatures of natural selection in the human genome. Nat Rev Genet 2003;4:99-111.
99. McQuillan LP, Leung GK, Marsden PA, Kostyk SK, Kourembanas S. Hypoxia inhibits expression of eNOS via transcriptional and posttranslational mechanisms. Am J Physiol 1994;267:H1921-7.
100. Bodi I, Bishopric NH, Discher DJ, Wu X, Webster KA. Cell-specificity and signaling pathway of endothelin-1 gene regulation by hypoxia. Cardiovasc Res 1995;30:975-84.
101. Melillo G, Musso T, Sica A, Taylor LS, Cox GW, Varesio L. A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter. J Exp Med 1995; 182:1683-93.
102. Camenisch G, Stroka DM, Gassmann M, Wenger RH. Attenuation of HIF-1 DNA-binding activity limits hypoxia-inducible endothelin-1 expression. Pflugers Arch Gesamte Physiol Menschen Tiere 2001; 443:240-9.
103. Kimura H, Esumi H. Reciprocal regulation between nitric oxide and vascular endothelial growth factor in angiogenesis. Acta Biochim Pol 2003;50:49-59.
104. Grosfeld A, Andre J, Hauguel-De Mouzon S, Berra E, Pouyssegur J, Guerre-Millo M. Hypoxia-inducible factor 1 transactivates the human leptin gene promoter. J Biol Chem 2002;277:42953-7.
105. Meissner U, Ostreicher I, Allabauer I, Rascher W, Dotsch J. Synergistic effects of hypoxia and insulin are regulated by different transcriptional elements of the human leptin promoter. Biochem Biophys Res Commun 2003;303:707-12.
106. Czyzyk-Krzeska MF, Bayliss DA, Lawson EE, Millhorn DE. Regulation of tyrosine hydroxylase gene expression in the rat carotid body by hypoxia. J Neurochem 1992;58:1538-46.
107. Schobel HP, Fischer T, Heuszer K, Geiger H, Schmieder RE. Preeclampsia - a state of sympathetic overactivity. N Engl J Med 1996; 335:1480-5.
108. Smiley RM, Finster M. Do receptors get pregnant too? Adrenergic receptor alterations in human pregnancy. J Matern Fetal Med 1996; 5:106-14.
109. Goldberg MA, Gaut CC, Bunn HF. Erythropoietin mRNA levels are governed by both the rate of gene transcription and posttranscriptional events. Blood 1991;77:271-7.
110. Rolfs A, Kvietikova I, Gassmann M, Wenger RH. Oxygen-regulated transferrin expression is mediated by hypoxia-inducible factor-1. J Biol Chem 1997;272:20055-62.
111. Ostlund E, Lindholm H, Hemsen A, Fried G. Fetal erythropoietin and endothelin-1: relation to hypoxia and intrauterine growth retardation. Acta Obstet Gynecol Scand 2000;79:276-82.
112. Zelzer E, Levy Y, Kahana C, Shilo BZ, Rubinstein M, Cohen B. Insulin induces transcription of target genes through the hypoxia-inducible factor HIF-1alpha/ARNT. EMBO J 1998;17:5085-94.
113. Zamudio S, Broad E, Niccoli S, Bhatia S, Tissot Van Patot MC, Faessen G et al. IGFBP-1 and IGF-1 in high vs. moderate altitude pregnancy. J Soc Gynecol Investig 2000;7:252A.
114. Constancia M, Hemberger M, Hughes JM, Dean W, Ferguson-Smith A, Fundele R et al. Placental-specific IGF-II is a major modulator of placental and fetal growth. Nature 2002;417:945-8.
115. Martinez-Chequer JC, Stouffer RL, Hazzard TM, Patton PE, Molskness TA. Insulin-like growth factors-1 and -2, but not hypoxia, synergize with gonadotropin hormone to promote vascular endothelial growth factor - a secretion by monkey granulosa cells from preovulatory follicles. Biol Reprod 2003;68:1112-8.
116. Heinig J, Wilhelm S, Muller H, Briese V, Bittorf T, Brock J. Determination of cytokine mRNA-expression in term human placenta of patients with gestational hypertension, intrauterine growth retardation and gestational diabetes mellitus using polymerase chain reaction. Zentralbl Gynakol 2000;122:413-8.
117. Gorlach A, Diebold I, Schini-Kerth VB, Brechner-Pfannschmidt U, Roth U, Brandes RP et al. Thrombin activates the hypoxia-inducible factor-1 signaling pathway in vascular smooth muscle cells: Role of the p22(phox)-containing NADPH oxidase. Circ Res 2001;89:47-54.
118. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992;359:843-5.
119. Gleadle JM, Ebert BL, Firth JD, Ratcliffe PJ. Regulation of angiogenic growth factor expression by hypoxia, transition metals and chelating agents. Am J Physiol 1995;268:C1362-8.
120. Gerber HP, Condorelli F, Park J, Ferrara N. Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia. J Biol Chem 1997;272:23659-67.
121. Khaliq A, Dunk C, Jiang J, Shams M, Li XF, Acevedo C et al. Hypoxia down-regulates placenta growth factor, whereas fetal growth restriction up-regulates placenta growth factor expression: molecular evidence for "placental hyperoxia" in intrauterine growth restriction. Lab Invest 1999;79:151-70.
122. Halder JB, Zhao X, Soker S, Paria BC, Klagsbrun M, Das SK et al. Differential expression of VEGF isoforms and VEGF(164)-specific receptor neuropilin-1 in the mouse uterus suggests a role for VEGF(164) in vascular permeability and angiogenesis during implantation. Genesis 2000;26:213-24.
123. Neufeld G, Kessler O, Herzog Y. The interaction of Neuropilin-1 and Neuropilin-2 with tyrosine-kinase receptors for VEGF. Adv Exp Med Biol 2000;515:81-90.
124. Ong CY, Liao AW, Cacho AM, Spencer K, Nicolaides KH. First-trimester maternal serum levels of placenta growth factor as predictor of preeclampsia and fetal growth restriction. Obstet Gynecol 2001; 98:608-11.
125. Elvert G, Kappel A, Heidenreich R, Englemeier U, Lanz S, Acker T et al. Cooperative interaction of hypoxia-inducible factor-2α (HIF-2α) and Ets-1 in the transcriptional activation of vascular endothelial growth factor receptor-2 (Flk-1). J Biol Chem 2003;278:7520-30.
126. Trollmann R, Amann K, Schoof E, Beinder E, Wenzel D, Rascher W et al. Hypoxia activates the human placental vascular endothelial growth factor system in vitro and in vivo: up-regulation of vascular endothelial growth factor in clinically relevant hypoxic ischemia in birth asphyxia. Am J Obstet Gynecol 2003;188:517-23.
127. Benyo DF, Miles TM, Conrad KP. Hypoxia stimulates cytokine production by villous explants from the human placenta. J Clin Endocrinol Metab 1997;182:1582-8.
128. Hellwig-Bürgel T, Rutkowski K, Metzen E, Fandrey J, Jelkmann W. Interleukin-1β and tumor necrosis factor-α stimulate DNA binding of hypoxia-inducible factor-1, Blood 1999; 94:1561-7.
129. Lea RG, Riley SC, Antipatis C, Hannah L, Ashworth CJ, Clark DA et al. Cytokines and the regulation of apoptosis in reproductive tissues: a review. Am J Reprod Immunol 1999;42:100-9.
130. Rinehart BK, Terrone DA, Lagoo-Deenadayalan S, Barber WH, Hale EA, Martin JN et al. Expression of the placental cytokines tumor necrosis factor alpha, interleukin 1beta, and interleukin 10 is increased in preeclampsia. Am J Obstet Gynecol 1999;181:915-20.
131. Thornton RD, Lane P, Borghaei RC, Pease EA, Caro J, Mochan E. Interleukin 1 induces hypoxia-inducible factor 1 in human gingival and synovial fibroblasts. Biochem J 2000;350:307-12.
132. Coussons-Read ME, Mazzeo RS, Whitford MH, Schmitt M, Moore LG, Zamudio S. High altitude residence during pregnancy alters cytokine and catecholamine levels. Am J Reprod Immunol 2002; 48:344-54.
133. Chan WK, Yao G, Gu YZ, Bradfield CA. Cross-talk between the aryl hydrocarbon receptor and hypoxia inducible factor signaling pathways. J Biol Chem 1999;274:12115-23.
134. Daikoku T, Matsumoto H, Gupta RA, Das SK, Gassmann M, DuBois RN et al. Expression of hypoxia-inducible factors in the peri-implantation mouse uterus is regulated in a cell-specific and ovarian steroid hormone-dependent manner. Evidence for differential function of HIFs during early pregnancy. J Biol Chem 2003;278:7683-91.
135. Rajakumar A. The hypoxia inducible transcription factor, HIF-1a, overexpressed in preeclamptic placentas is capable of binding to the hypoxia response element. J Soc Gynecol Investig 2003;10:304A.
136. Jeong JW, Bae MK, Ahn MY, Kim SH, Sohn TK, Bae MH et al. Regulation and destabilization of HIF-1alpha by ARD1-mediated acetylation. Cell 2002;111:709-20.
137. Bae MK, Ahn MY, Jeong JW, Bae MH, Lee YM, Bae SK et al. Jab1 interacts directly with HIF-1alpha and regulates its stability. J Biol Chem 2002;277:9-12.
138. Cope GA, Suh GS, Aravind L, Schwarz SE, Zipursky SL, Koonin EV et al. Role of predicted metalloprotease motif of Jab1/Csn5 in cleavage of Nedd8 from Cull. Science 2002;298:608-11.
139. Ietta F, Todros T, Ticconi C, Piccoli E, Zicari A, Piccione E et al. Macrophage migration inhibitory factor in human pregnancy and labor. Am J Reprod Immunol 2002;48:404-9.
140. Helaakoski T, Vuori K, Myllyla R, Kivirikko KI, Pihlajaniemi T. Molecular cloning of the alpha-subunit of human prolyl 4-hydroxylase: the complete cDNA-derived amino acid sequence and evidence for alternative splicing of RNA transcripts. Proc Natl Acad Sci U S A 1989; 86:4392-6.
141. Cioffi CL, Qin Liu X, Kosinski PA, Garay M, Bowen BR. Differential regulation of HIF-1alpha prolyl-4-hydroxylase genes by hypoxia in human cardiovascular cells. Biochem Biophys Res Commun 2003; 303:947-53.
142. Hon WC, Wilson MI, Harlos K, Claridge TD, Schofield CJ, Pugh CW et al. Structural basis for the recognition of hydroxyproline in HIF-1 alpha by pVHL. Nature 2002;417:975-8.